The utility of the Mattis Dementia Rating Scale 2 (MDRS-2) in screening for dementia in Parkinson disease (PD) is well documented. However, little is known about its sensitivity to mild cognitive impairment in PD (PD-MCI). This study sought to document the validity of the MDRS-2 for diagnoses of PD-MCI and dementia in PD (PDD). Twenty-two healthy controls (HCs), 22 PD-MCI, and 16 PDD were compared on each MDRS-2 subscales and MDRS-2 total standard scores. Patients with PDD performed significantly worse than the other groups (all Ps < .05) on the MDRS-2 total and on all subscales, except attention. PD-MCI had significant lower scores than HCs on the MDRS-2 total and on initiation/perseveration and memory subscales. The optimal cutoff score for PD-MCI diagnosis was ≤ 140/144 and ≤ 132/144 for PDD. These findings suggest that MDRS-2 is a useful tool to identify dementia but that there might be a ceiling effect in the MDRS-2 cutoff score to diagnose MCI in PD.
ChaudhuriKRHealyDGSchapiraAH. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol. 2006;5(3):235–245.
2.
AarslandDKurzMW. The epidemiology of dementia associated with Parkinson disease. J Neurol Sci. 2010;289(1-2):18–22.
3.
PetersenRC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256(3):183–194.
4.
AarslandDBronnickKLarsenJPTysnesOBAlvesG. Cognitive impairment in incident, untreated Parkinson disease. Neurology. 2009;72(13):1121–1126.
5.
JanvinCCLarsenJPAarslandDHugdahlK. Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. Mov Disord. 2006;21(9):1343–1349.
6.
CavinessJNDriver-DunckleyEConnorDJDefining mild cognitive impairment in Parkinson's disease. Mov Disord. 2007;22(9):1272–1277.
7.
HolroydSCurrieLWootenGF. Prospective study of hallucinations and delusions in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2001;70(6):734–738.
8.
SchragABaronePBrownRGDepression rating scales in Parkinson's disease: critique and recommendations. Mov Disord. 2007;22(8):1077–1092.
9.
AarslandDAndersenKLarsenJPLolkAKragh-SorensenP. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol. 2003;60(3):387–392.
10.
BurnDJMcKeithIG. Current treatment of dementia with Lewy bodies and dementia associated with Parkinson's disease. Mov Disord. 2003;18(suppl 6):S72–S79.
11.
RiedelOKlotscheJSpottkeACognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German study on epidemiology of parkinson's disease with dementia (GEPAD). J Neurol.2008;255(2):255–264.
12.
MamikonyanEMobergPJSiderowfAMild cognitive impairment is common in Parkinson's disease patients with normal mini-mental state examination (MMSE) scores. Parkinsonism Relat Disord. 2009;15(3):226–231.
13.
NasreddineZSPhillipsNABedirianVThe Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc.2005;53(4):695–699.
14.
Dalrymple-AlfordJCMacaskillMRNakasCTThe MoCA: well-suited screen for cognitive impairment in Parkinson disease. Neurology. 2010;75(19):1717–1725.
15.
CoblentzJMMattisSZingesserLHKasoffSSWisniewskiHMKatzmanR.Presenile dementia. Clinical aspects and evaluation of cerebrospinal fluid dynamics. Arch Neurol. 1973;29(5):299–308.
16.
MattisS. Mental status examination for organic mental syndrome in the elderly patient. In: BellakTKarasiTB, eds. Geriatric Psychiatry. New York, NY: Crane and Stratten; 1976:77–121.
17.
AarslandDLitvanISalmonDGalaskoDWentzel-LarsenTLarsenJP. Performance on the Dementia Rating Scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2003;74(9):1215–1220.
18.
LlebariaGPagonabarragaJKulisevskyJCut-off score of the Mattis Dementia Rating Scale for screening dementia in Parkinson's disease. Mov Disord. 2008;23(11):1546–1550.
19.
DuboisBBurnDGoetzCDiagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord. 2007;22(16):2314–2324.
20.
HughesAJBen-ShlomoYDanielSELeesAJ. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology. 1992;42(6):1142–1146.
21.
HughesAJDanielSELeesAJ. Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology. 2001;57(8):1497–1499.
22.
DelisDCKaplanEKramerJH. Delis-Kaplan Executive Function System. San Antonio, TX: The Psychological Corporation; 2001.
23.
WeschlerD. Weschler Adult Intelligence Scale. 3rd ed. San Antonio, TX: The Psychological Corporation; 1997.
24.
DelisDCKramerJHKaplanEFOberBA. California Verbal Learning Test: Adult Version Manual. San Antonio, TX: The Psychological Corporation; 1987.
25.
CahnDASalmonDPMonschAUScreening for dementia of the Alzheimer type in the community: the utility of the clock drawing test. Arch Clin Neuropsychol. 1996;11(6):529–539.
26.
HoehnMMYahrMD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17(5):427–442.
27.
HamiltonM. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6(4):278–296.
28.
LeentjensAFVerheyFRLousbergRSpitsbergenHWilminkFW. The validity of the Hamilton and Montgomery-Asberg depression rating scales as screening and diagnostic tools for depression in Parkinson's disease. Int J Geriatr Psychiatry. 2000;15(7):644–649.
WinbladBPalmerKKivipeltoMMild cognitive impairment—beyond controversies, towards a consensus: report of the international working group on mild cognitive impairment. J Intern Med. 2004;256(3):240–246.
31.
FortIAdoulLHollDKaddourJGanaK. Psychometric properties of the French version of the multifactorial memory questionnaire for adults and the elderly. Can J Aging. 2004;23(4):347–357.
32.
GauthierSGelinasIGauthierL. Functional disability in Alzheimer's disease. Int Psychogeriatr. 1997;9(suppl 1):163–165.
33.
EmreMAarslandDBrownRClinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord. 2007;22(12):1689–1707; quiz 837.
34.
WarnerJ. Clinicians' guide to evaluating diagnostic and screening tests in psychiatry. Adv Psychiat Treatment. 2004;10(6):446–454.
35.
JaeschkeRGuyattGLijmerJ. Diagnostic tests. In: GuyattGRennieD, eds. User's Guides to the Medical Literature. Chicago, IL: American Medical Association Press; 2002:121–140.
36.
HoopsSNazemSSiderowfADValidity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology. 2009;73(21):1738–1745.
37.
PagonabarragaJKulisevskyJLlebariaGGarcia-SanchezCPascual-SedanoBGironellA. Parkinson's disease-cognitive rating scale: a new cognitive scale specific for Parkinson's disease. Mov Disord. 2008;23(7):998–1005.
PetersenRCStevensJCGanguliMTangalosEGCummingsJLDeKoskyST. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the quality standards subcommittee of the American academy of neurology. Neurology.2001;56(9):1133–1142.
40.
MahieuxFFenelonGFlahaultAManifacierMJMicheletDBollerF. Neuropsychological prediction of dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1998;64(2):178–183.
41.
BohnenNIKauferDIHendricksonRCognitive correlates of cortical cholinergic denervation in Parkinson's disease and parkinsonian dementia. J of Neurol. 2006;253(2):242–247..
42.
WoodsSPTrosterAI. Prodromal frontal/executive dysfunction predicts incident dementia in Parkinson's disease. J Int Neuropsychol Soc. 2003;9(1):17–24.
43.
SongIUKimJSJeongDSSongHJLeeKS. Early neuropsychological detection and the characteristics of Parkinson's disease associated with mild dementia. Parkinsonism Relat Disord. 2008;14(7):558–562.
44.
KulisevskyJPagonabarragaJ. Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment. Mov Disord. 2009;24(8):1103–1110.
45.
LitvanIGoldmanJGTrösterAIDiagnostic criteria for mild cognitive impairment in in Parkinson's disease: movement disorder society task force guidelines. Mov Disord. 2012;27(3):349–356. doi: 10.1002/mds.24893.
